ClinicalTrials.gov
public full text
Public Domain
Harmonizing RCT-Duplicate Emulations In A Real World Replication Program (HARRP)
clinical-trialepidemiologyreal-world-datareal-world-evidenceregulatorytype-2-diabetestype-2-diabetes-mellitus
Replication of three clinical trial emulations CANVAS, LEADER, and SAVOR TIMI that form part of the RCT-Duplicate initiative, sponsored by the FDA and delivered by the Brigham and Women's Hospital and Harvard Medical School. AstraZeneca will use the Instant Health Data platform PANALGOS (IHD) for the analyses.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Replication Studies: Not Just a Copy#1011875
- From digital control to digital twins in medicine: A brief review and future perspectives#460986
- Role of health digital twins in oncology drug development - a primer.#671260
- Randomized Trial of Treatments for Convergence Insufficiency#1046801
- Data Integrity Failures in Pharmaceutical Digital Twins and Continuous Manufacturing: An Alcoa + + Framework Integrating Human Factors and Simulation Vulnerabilities#241001
Record · ID 806408
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive